Early research (Phase 1)Active Not RecruitingNCT06547944
What this trial is testing
Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNewly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China 30